The metabonomic differences were mainly associated with ABC transporters, glycerophospholipid metabolism, purine metabolism and central carbon metabolism in cancer and may be attributed to the difference of tumor microenvironment caused by different location of implantation. The gene discussed is ABCG2; the disease is neoplasm.